@CircRes Compendium on #Lipoproteins and #CVD #CETP Inhibitors: Back with a New Target ahajrnls.org/4vC1yTf Authored by Drs.Nicholls & colleagues @ProfSNicholls @ajnelson @ProfKausikRay @johnkastelein

A note from our Editor-in-Chief, @BiancaRoccaTwt : Few days ago, we held the first meeting of the renewed EHJ-CVP Editorial Board. 🌍Colleagues dialled in from across Asia, Australia, Europe and North America. Some from very late time zones. Honoured to have Prof. Parkhomenko join from Kyiv. Multidisciplinary, global, with strong representation of women across the Board. Exactly the team this journal needs. I left the meeting genuinely energised. There is a lot we want to do together. We are united in purpose and stronger in advocacy for better and inclusive cardiovascular pharmacotherapy. #EHJCVP #Cardiology #ClinicalPharmacology #Pharmacotherapy @ESC_Lavinia @ESC_Journals @escardio @Massimi78530343 @doreen_sy @OtiliaTica1 @Costa_F_8

Impressive quality of submitted science driving the growth of cardiovascular knowledge🚀5869 abstracts&549 clinical cases accepted for #ESCCongress Munich🇩🇪 A huge step forward for science & collaboration🔬 Programme now live—Spread the word Programme is now available online esc365.escardio.org/ESC-Cong… @BiancaRoccaTwt @ESC_Journals @ESC_Camille @Massimi78530343 @doreen_sy @OtiliaTica1 @Costa_F_8

🚨New in EHJ-CVP🚨 HFpEF and HFmrEF therapies continue to evolve rapidly💊 This pre-specified Bayesian analysis of FINEARTS-HF adds another layer to the finerenone story — strengthening the probability of benefit for reducing worsening HF events and CV death across the preserved EF spectrum. How do you see Bayesian analyses influencing the way we interpret HF trials and future guideline adoption?📊 Read the article in EHJ-CVP: 🔗doi.org/10.1093/ehjcvp/pvag0…

📢New in EHJ-CVP: The journal introduces Rapid Communications📜: a new concise article format for focused clinical & translational research🚀 ≤1000 words (excluding references), emphasis on methods/results, 1 figure/table, no abstract or supplementals. Fast, focused, impactful science!🔬 🔗academic.oup.com/ehjcvp/page… @BiancaRoccaTwt @doreen_sy @OtiliaTica1 @Massimi78530343 @Costa_F_8 @ESC_Journals @ESCardioNews

📢The new #EHJCVP issue is now online💥the first under Editor-in-Chief Prof. Bianca Rocca & the new editorial board!✍🏼 From innovation in CV pharmacotherapy to research integrity and cutting-edge science across the field🔬the issue opens with an editorial from EiC, setting the tone for journal's direction➡️ 🔗academic.oup.com/ehjcvp/issu… @BiancaRoccaTwt @doreen_sy @Massimi78530343 @Costa_F_8 @ESCardioNews @ESC_Journals

🆕A new era for #EHJCVP➡️ With this first editorial, we are proud to welcome an international & multidisciplinary Board committed to innovation, diversity, patient-centred care🫀and rigorous science📚 Together, shaping the future of cardiovascular pharmacotherapy🌍💊 🔗doi.org/10.1093/ehjcvp/pvag0…

Excited to start this new journey with #EHJCVP under the new leadership of @EditorEHJCVP. Many innovations ahead !

Pan & colleagues detected #micro(nano)plastics in human #heart tissue, & higher tissue levels were associated with greater #fibrosis. Learn more about a possible role for plastic particles in adverse cardiac remodeling at ahajrnls.org/4dQBYlQ

Meral et al found cell type-resolved #transcriptomics reveal that diastolic dysfunction is linked to a reversible shift in #fibroblast states, driven by #mineralocorticoid receptor signaling. Learn more at ahajrnls.org/4nKKJCz @MeralDavid

Yoon & colleagues found that the secreted glycoprotein #VEGF-D enhanced endothelial barrier function & conferred protection against #inflammatory in acute #lung injury models. Learn more at ahajrnls.org/4cFUbn4 @kaminskimed

Last reminder: Secure your spot at the forefront of #CVImaging & #HeartFailure Management - Join #PCHFImaging 🫀imaging.heartfailurecourse.c… @Unispital_USZ @UZH_en @HFA_President @FrancescoPaneni @rmanka_ @Alkadhi_rad @s_e_petersen @VDelgadoGarcia @EACVIPresident #EACVI #CardioX

Congratulations to @Lux_Telesca for being awared the prestigious Guido Tarone Award at the HF Winter Meeting 2026 in Berlin! #HFpEF #PH #obesity #CostantinoLab @FrancescoPaneni @UZH_ch @CardioZurich @Unispital_USZ

What an achievement of the @PaneniLab ! Congratulations to our Director @FrancescoPaneni and his team!

Wissemann et al found #obesity is associated with an accumulation of pro-inflammatory, externalized #inflammasome particles in visceral fat. Learn how to tackle chronic #inflammation in #CVD at ahajrnls.org/4rGudVZ @AndreasZirlik @VasclmmunLab @dirkwestermann

🚨Our new article is now out in #JCI @jclinicalinvest! Together with #Frank_Ruschitzka and @VidalPuig, we highlight how gut #microbiota is emerging as a therapeutic target in #cardiovascular disease. #Saeedi_Lab @CTECresearch @CardioZurich @FrancescoPaneni @EricTopol @agingdoc1

@CircRes welcomes the submission of Research Letters to accompany a Compendium on Migration of Mitochondria Beyond Cell Boundary: Biology, Physiology, and Therapeutic Potential. Initial submissions are due no later than December 29, 2025. More info here: ahajrnls.org/3O66En5

Congratulations to @LDiVenanzio for winning the best poster award at the #CBHF meeting in Naples! Well done Ludovica👏👏👏

#CardiovascularDiabetology @BioMedCentral Awards Associate Editors of the Year 2025 🎉🏅 Cardiovascular Diabetology is delighted to announce the Associate Editors of the Year 2025: ✨ Prof. @DidacMauricio ✨ Prof. @FrancescoPaneni This recognition highlights their outstanding dedication, leadership, and invaluable contributions to advancing scientific progress in cardiovascular health and diabetes research 👏👏👏. communities.springernature.c…

Two days left to submit an abstract for oral presentation or poster for the New Cardiobiology at EMBL Heidelberg. Don’t miss it. Engineering and Cardiovascular is the future! Deadline extended to Nov 17th!